Summary List Placement
The UK government has awarded at-home blood-testing startup Thriva a £61.8 million ($80 million) contract to help scale up COVID-19 testing capacity.
Prime Minister Boris Johnson has faced extensive criticism over the past few months for failing to deliver his much-promised “world beating” test-and-trace system, with senior scientists claiming the scheme had so far had a “marginal impact”.
Thriva is a commercial, privately owned startup best known for offering at-home blood tests to help determine a person’s risk for diabetes, heart disease, and other conditions.
A source told Business Insider last week that Thriva had been awarded a contract amounting to $5 million per month to provide the UK with COVID-19 antibody tests. These mostly involve taking a blood sample at home, then posting the sample off to a lab to analyze for antibodies. The test shows whether a person has previously been infected with the coronavirus, but not whether they are currently sick.
Data published by Trussell on Tuesday, an online platform monitoring government contracts, confirmed the contract. Thriva was awarded £61.8 million (around $80 million) to help improve capacity.
According to a public notice, Thriva has been enlisted to provide an “end-to-end serology testing service … working with a network of …read more
Source:: Businessinsider – Tech